Why We Do It
We are invested in making a meaningful difference in the lives of patients and their families around the globe.
We do this by advancing innovative solutions for clinical practice that are sustainable, cost-effective and accessible.
“We wouldn’t be alive today without Fogarty Innovation.”
– Company-In-Residence CEO
At our core…
We behave with integrity first and foremost, knowing we affect the lives of patients and their loved ones.
We put team before self, valuing mutual trust and respect for each other, and sharing a foundational belief that strong teams enhance performance.
We believe in equality and seek diversity to keep growing as a team — not only in race and gender, but also in expression.
We value continuous learning, both as teachers and perpetual students.
We believe the process of innovation is a discipline that can be taught and honed.
We trust in the power of an audacious vision because it taps into a basic human desire: belonging to and believing in something bigger than ourselves.
We have a sense of wonder and a spirit of adventure as we push boundaries to create positive impact on the global medical ecosystem.
We stay humble for all that remains to be done in shaping the future of human health.
We believe these things because we have seen the power of their impact
Thanks to its recent acquisition by Merck on behalf of its planned spinoff of Organon, Alydia Health, a Fogarty Innovation graduate, is one step closer to its goal of eradicating postpartum hemorrhage (PPH), the leading global cause of maternal death. The deal is...
Securing financial backing is always a hot topic for startups, and never more so than today, when COVID-19 has upset the traditional landscape. That was the topic of “Medtech Innovation: The Post-COVID World of Innovation,” at the recent Transcatheter...
Fogarty Innovation in the Spotlight During Presentation to FDA Staff on Bringing Innovative Ideas to Market
It’s always encouraging to hear about medtech entrepreneurs finding success. But have you ever wondered how they got there? The road, as you’d assume, is not straight, as nearly 100 FDA participants heard from successful entrepreneurs at an engaging, educational panel...